Safety and preliminary efficacy of ivaltinostat, an HDAC inhibitor, plus capecitabine in patients with pretreated metastatic pancreatic adenocarcinoma (mPDAC): Results of a phase Ib study

Document Type

Conference Proceeding

Publication Date

1-27-2025

Publication Title

Journal of Clinical Oncology (2025) 43 Supplement 4. Date of Publication: 1 Feb 2025

Abstract

2025 ASCO Gastrointestinal Cancers Symposium, January 23 - 25, 2025, San Francisco, CA

Volume

43

Comments

Abstract 742

Share

COinS